** Shares of China's WuXi Biologics 2269.HK fall 5.9% to HK$15.62, on track for their biggest one-day pct drop since Oct 15 if current losses hold
** Stock hits the lowest level since Dec 3 on its second straight session of decline; second-biggest pct loser in the Hang Seng Index .HSI, which slips 0.6%
** Co said on Monday it would sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co MRK.N for about $500 mln, ahead of potential U.S. legislation that would restrict business for Chinese biotech companies
** The U.S. House of Representatives passed the Biosecure Act in September, which would ban federal contracts with targeted firms and their business partners
** The Hang Seng Commerce & Industry Index .HSNC eases 0.8% and the healthcare index .HSCIH declines 0.7%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.